Expression and clinical significance of PTI-1 in prostate cancer tissues
Zhou Yu
Abstract
Zhou Yu
Abstract
AIM: To study the expression and clinical significance of PTI-1 in prostate cancer tissues. METHODS: PTI-1 was examined in 21 cases of prostate cancer tissues, 12 cases of benign prostatic hyperplasia (BPH) and 9 cases of normal prostate tissues by reverse transcription-polymerase chain raction (RT-PCR). RESULTS: Specific bands of PTI-1 were found in RT-PCR products of 15 cases of prostate cancer tissues, but not in BPH and normal prostate tissues. CONCLUSION: Detection of PTI-1 by RT-PCR can be used in diagnosing prostate cancer.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM: To study the expression and clinical significance of PTI-1 in prostate cancer tissues. METHODS: PTI-1 was examined in 21 cases of prostate cancer tissues, 12 cases of benign prostatic hyperplasia (BPH) and 9 cases of normal prostate tissues by reverse transcription-polymerase chain raction (RT-PCR). RESULTS: Specific bands of PTI-1 were found in RT-PCR products of 15 cases of prostate cancer tissues, but not in BPH and normal prostate tissues. CONCLUSION: Detection of PTI-1 by RT-PCR can be used in diagnosing prostate cancer.
Key concepts: Prostate cancer, Prostate, Hyperplasia, Medicine, PCA3, Clinical significance, Prostate Diseases, Reverse transcription polymerase chain reaction